Skip to main content
. Author manuscript; available in PMC: 2014 Aug 22.
Published in final edited form as: JAMA Dermatol. 2014 Jul;150(7):716–723. doi: 10.1001/jamadermatol.2013.8116

Table 2.

Cox Proportional Hazard Models of Host and Tumor Variables on Outcomes in 217 Patientsa

Outcome
Locoregional Recurrence (47 Events)
Distant Metastasis (38 Events)
All-Cause Mortality (147 Events)
Disease-Specific Mortality (56 Events)
AHR (95% CI) Events, No. AHR (95% CI) Events, No. AHR (95% CI) Events, No. AHR (95% CI) Events, No.
Host Variables

Age, y

 <75 1 [Reference] 21 1 [Reference] 20 1 [Reference] 48 1 [Reference] 27

 ≥75 0.7 (0.4–1.4) 26 0.8 (0.4–1.6) 18 1.9 (1.3–2.8) 99 1.2 (0.6–2.2) 29

Sex

 Female 1 [Reference] 12 1 [Reference] 12 1 [Reference] 52 1 [Reference] 20

 Male 1.4 (0.7–2.8) 35 1.7 (0.8–3.4) 26 1.3 (0.9–1.8) 95 1.2 (0.7–2.2) 36

Immunosuppression

 None 1 [Reference] 45 1 [Reference] 37 1 [Reference] 138 1 [Reference] 51

 Yes 1.1 (0.2–5.3) 2 0.6 (0.1–4.6) 1 1.9 (0.9–4.0) 9 4.9 (1.7–14.4) 5

Tumor Variables

Anatomic site

 Limbs/trunk/other b 24 1 [Reference] 18 1 [Reference] 60 1 [Reference] 22

 Head/neck 23 1.1 (0.5–2.3) 18 0.9 (0.6–1.3) 69 0.9 (0.4–1.7) 23

 Unknown 0 0.1 (0.0–0.7) 2 0.4 (0.2–0.9) 18 0.6 (0.2–1.9) 11

Size, cm

 ≤2 1 [Reference] 19 1 [Reference] 14 1 [Reference] 45 1 [Reference] 15

 >2 1.7 (0.7–4.3) 8 1.1 (0.4–3.1) 6 0.8 (0.5–1.6) 17 1.1 (0.4–2.9) 9

 Unknown 0.7 (0.4–1.5) 20 0.8 (0.4–1.8) 18 1.0 (0.7–1.5) 85 0.8 (0.4–1.7) 32

Extent, at diagnosis

 Local 1 [Reference] 27 1 [Reference] 19 1 [Reference] 79 1 [Reference] 18

 Regional 2.9 (1.2–7.3) 13 4.2 (1.6–10.7) 12 2.7 (1.5–4.7) 36 5.3 (2.3–12.3) 21

 Distant 3.8 (1.3–11.4) 7 3.2 (1.1–9.2) 7 3.6 (2.1–6.1) 32 7.0 (2.9–16.5) 17

Abbreviation: AHR, adjusted hazard ratio.

a

Adjusted for all other variables listed in table, except the race variable, which is excluded due to sparse data in nonwhite strata. One individual with no staging data was excluded from all adjusted models.

The 95% CIs were calculated using the Wald method.

b

No locoregional recurrences in individuals with no known primary by definition of recurrence.